Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

InflaRx NV sell djassam

Start price
€1.35
21.12.23 / 50%
Target price
-
21.12.24
Performance (%)
-17.56%
Price
€1.11
13:05
Summary
This prediction is currently active. The prediction for InflaRx NV shows a convincing performance of -17.56%. This prediction currently runs until 21.12.24. The prediction end date can be changed by djassam at any time. djassam has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
InflaRx NV -13.704% -13.704%
iShares Core DAX® 4.094% 4.888%
iShares Nasdaq 100 1.424% -0.445%
iShares Nikkei 225® -1.572% -4.911%
iShares S&P 500 1.822% 0.776%

Comments by djassam for this prediction

In the thread InflaRx NV diskutieren
Prediction Sell
Perf. (%) -17.56%
Target price
Change
Ends at

The comment has been deleted

InflaRx's commitment to innovative therapies in immunology, particularly in addressing inflammatory diseases, is commendable. Their focus on cutting-edge research, especially with IFX-1's clinical trials, showcases their dedication to meeting unmet medical needs - pokedoku